Hims & Hers Health (XSWX:HIMS) Selling, General, & Admin. Expense: CHF1,243.85 Mil (TTM As of Mar. 2026)


XSWX:HIMS Hims & Hers Health Inc XSWX:HIMS
81 GF Score
Price CHF29.90
GF Value CHF32.30
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Selling, General, & Admin. Expense?

Hims & Hers Health XSWX:HIMS 81 Selling, General, & Admin. Expense is CHF1,243.85 Mil as of Mar. 2026. GuruFocus rates XSWX:HIMS with a GF Score™ of 81/100 and a GF Value™ of CHF32.30. The stock has 3 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Hims & Hers Health's selling, general, & admin. expense for the three months ended in Mar. 2026 was CHF331.67 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1,243.85 Mil.


Hims & Hers Health  (XSWX:HIMS) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Hims & Hers Health Selling, General, & Admin. Expense Related Terms


Hims & Hers Health Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Selling, General, & Admin. Expense Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
Get a 7-Day Free Trial 249.56 370.78 576.32 846.61 1,192.02

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 279.85 285.14 312.83 314.21 331.67

XSWX:HIMS vs : Selling, General, & Admin. Expense Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hims & Hers Health Selling, General, & Admin. Expense vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's Selling, General, & Admin. Expense falls into.


XSWX:HIMS
81GF Score
Hims & Hers Health Inc XSWX:HIMS
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,243.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of CHF1,243.85 Mil mean?
Hims & Hers Health (XSWX:HIMS) has a Selling, General, & Admin. Expense of CHF1,243.85 Mil as of Mar. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Selling, General, & Admin. Expense too high?
Hims & Hers Health's current Selling, General, & Admin. Expense is CHF1,243.85 Mil. Overall, Hims & Hers Health has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Selling, General, & Admin. Expense compare to ?
Hims & Hers Health's Selling, General, & Admin. Expense of CHF1,243.85 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Drug Manufacturers company?
A good Selling, General, & Admin. Expense depends on the Drug Manufacturers industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Selling, General, & Admin. Expense is CHF1,243.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current Selling, General, & Admin. Expense of CHF1,243.85 Mil. The stock's GF Value™ is CHF32.30, compared to a current price of CHF29.90 — trading 7.4% below its estimated fair value. The current Selling, General, & Admin. Expense is CHF1,243.85 Mil. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current Selling, General, & Admin. Expense is CHF1,243.85 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of CHF29.90 is trading 7.4% below its estimated GF Value™ of CHF32.30.

Key valuation signals for XSWX:HIMS:

  • Selling, General, & Admin. Expense: CHF1,243.85 Mil
  • GF Value™: CHF32.30 vs. price of CHF29.90 (7.4% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hims & Hers Health Business Description

Comparable Companies
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score

Get the complete analysis for XSWX:HIMS

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF29.90
Price
CHF32.30
GF Value